EpiBiotech Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 12

Employees

  • Stock Symbol
  • 446440

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $3.66
  • (As of Friday Closing)

EpiBiotech General Information

Description

Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Contact Information

Formerly Known As
Stemore
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • M-Number 1903
  • 32, Songdogwahak-ro, Yeonsu-gu
  • Incheon, 21984
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
KRX
Corporate Office
  • M-Number 1903
  • 32, Songdogwahak-ro, Yeonsu-gu
  • Incheon, 21984
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EpiBiotech Stock Performance

As of 20-Nov-2026, EpiBiotech’s stock price is $3.66. Its current market cap is $8.45M.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.66 $3.19 $2.71 - $16.56 $8.45M 565.85 -$0.58

EpiBiotech Financials Summary

As of 31-Dec-2025, EpiBiotech has a trailing 12-month revenue of $1.36M.

In Thousands,
USD
TTM 31-Dec-2025 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2020 31-Dec-2020
EV 25,020 25,020
Revenue 1,355 1,355 536 217
EBITDA (45) (45) (2,252)
Net Income (1,342) (1,342) (3,576)
Total Assets 3,679 3,679 2,455 5,357
Total Debt 1,328 1,328 1,427 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

EpiBiotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EpiBiotech‘s full profile, request access.

Request a free trial

EpiBiotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin r
Drug Discovery
Incheon, South Korea
12 As of 2024

Vancouver, Canada
 

CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EpiBiotech Competitors (2)

One of EpiBiotech’s 2 competitors is 0913693 BC, a Corporation company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0913693 BC Corporation Vancouver, Canada
Stemsontx Venture Capital-Backed CA
You’re viewing 2 of 2 competitors. Get the full list »

EpiBiotech Patents

EpiBiotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024054006-A1 Novel genomic safe harbor and use thereof Inactive 05-Sep-2022
WO-2024010157-A1 Composition containing hair follicle cells Inactive 08-Jul-2022
EP-4435003-A1 Antibody to cxcl 12 and composition comprising same for treatment of hair loss Pending 27-Dec-2021
EP-4435003-A4 Antibody to cxcl 12 and composition comprising same for treatment of hair loss Pending 27-Dec-2021
WO-2023128494-A1 Antibody to cxcl 12 and composition comprising same for treatment of hair loss Inactive 27-Dec-2021 C07K16/24
To view EpiBiotech’s complete patent history, request access »

EpiBiotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EpiBiotech Investments (1)

EpiBiotech’s most recent deal was a Joint Venture with Joint Venture (Epi Biotech / Northland Biotech). The deal was made on 14-Apr-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Joint Venture (Epi Biotech / Northland Biotech) 14-Apr-2025 Joint Venture Clinics/Outpatient Services
To view EpiBiotech’s complete investments history, request access »

EpiBiotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view EpiBiotech’s complete esg history, request access »

EpiBiotech FAQs

  • When was EpiBiotech founded?

    EpiBiotech was founded in 2015.

  • Where is EpiBiotech headquartered?

    EpiBiotech is headquartered in Incheon, South Korea.

  • What is the size of EpiBiotech?

    EpiBiotech has 12 total employees.

  • What industry is EpiBiotech in?

    EpiBiotech’s primary industry is Drug Discovery.

  • Is EpiBiotech a private or public company?

    EpiBiotech is a Public company.

  • What is EpiBiotech’s stock symbol?

    The ticker symbol for EpiBiotech is 446440.

  • What is the current stock price of EpiBiotech?

    As of 20-Nov-2026 the stock price of EpiBiotech is $3.66.

  • What is the current market cap of EpiBiotech?

    The current market capitalization of EpiBiotech is $8.45M.

  • What is EpiBiotech’s current revenue?

    The trailing twelve month revenue for EpiBiotech is $1.36M.

  • Who are EpiBiotech’s competitors?

    0913693 BC and Stemsontx are competitors of EpiBiotech.

  • What is EpiBiotech’s annual earnings per share (EPS)?

    EpiBiotech’s EPS for 12 months was -$0.58.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process